|
|
Prepublished online as a Blood First Edition Paper on January 30, 2003; DOI 10.1182/blood-2002-05-1338.
 Previous Article | Table of Contents | Next Article 
Blood, 15 May 2003, Vol. 101, No. 10, pp. 4201-4208
TRANSPLANTATION
Albumin-expressing hepatocyte-like cells develop in the livers of
immune-deficient mice that received transplants of highly purified
human hematopoietic stem cells
Xiuli Wang,
Shundi Ge,
George McNamara,
Qian-Lin Hao,
Gay M. Crooks, and
Jan A. Nolta
From the Division of Research Immunology/Bone
Marrow Transplantation, Childrens Hospital Los Angeles (CHLA),
Los Angeles, CA; the Department of Pediatrics, University of Southern
California School of Medicine, Los Angeles, CA; and the Childrens
Hospital Los Angeles Research Institute, Congressman Dixon Cellular
Imaging Core, Los Angeles, CA.
Rodent bone marrow cells can contribute to liver. If these
findings are applicable to humans, marrow stem cells could
theoretically be harvested from a patient and used to repair
his/her damaged liver. To explore this potential,
CD34+ or highly purified
CD34+CD38 CD7 human
hematopoietic stem cells from umbilical cord blood and bone marrow were
transplanted into immunodeficient mice. One month after
transplantation, carbon tetrachloride (CCl4) was
administered into the mice to induce liver damage and hepatocyte
proliferation. Mice were analyzed in comparison with
CCl4-injured mice that did not receive transplants and
noninjured controls that received transplants with the same stem cell
populations, one month after liver damage. Human-specific albumin mRNA
and protein were expressed in the mouse liver and human albumin was
detected in the serum of mice that had received
CCl4 injury. Human alpha-fetoprotein was never
expressed, but in some mice, human cytokeratin 19 was expressed, which
may indicate bile duct development in addition to the albumin-secreting
hepatocyte-like cells. Human albumin was not expressed in the starting
stem cell populations in injured mice that did not receive transplants
nor in noninjured mice that had received transplants of human stem
cells. Human albumin expression was detected only in
CCl4-treated mice that received transplants of human stem
cells, and recovery was increased by administration of human hepatocyte
growth factor 48 hours after the CCl4-mediated liver injury. Our studies provide evidence that human
"hematopoietic" stem/progenitor cell populations have the capacity
to respond to the injured liver microenvironment by inducing albumin expression.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
N. Yadav, S. Kanjirakkuzhiyil, S. Kumar, M. Jain, A. Halder, R. Saxena, and A. Mukhopadhyay
The therapeutic effect of bone marrow-derived liver cells in the phenotypic correction of murine hemophilia A
Blood,
November 12, 2009;
114(20):
4552 - 4561.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Brezillon, D. Kremsdorf, and M. C. Weiss
Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens
Dis. Model. Mech.,
September 1, 2008;
1(2-3):
113 - 130.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L V. di Bonzo, I Ferrero, C Cravanzola, K Mareschi, D Rustichell, E Novo, F Sanavio, S Cannito, E Zamara, M Bertero, et al.
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential
Gut,
February 1, 2008;
57(2):
223 - 231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ohnishi, S. Mizuno, and T. Nakamura
Inhibition of tubular cell proliferation by neutralizing endogenous HGF leads to renal hypoxia and bone marrow-derived cell engraftment in acute renal failure
Am J Physiol Renal Physiol,
February 1, 2008;
294(2):
F326 - F335.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Fujino, H. Hiramatsu, A. Tsuchiya, A. Niwa, H. Noma, M. Shiota, K. Umeda, M. Yoshimoto, M. Ito, T. Heike, et al.
Human cord blood CD34+ cells develop into hepatocytes in the livers of NOD/SCID/{gamma}cnull mice through cell fusion
FASEB J,
November 1, 2007;
21(13):
3499 - 3510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Shigemura, M. Okumura, S. Mizuno, Y. Imanishi, A. Matsuyama, H. Shiono, T. Nakamura, and Y. Sawa
Lung Tissue Engineering Technique with Adipose Stromal Cells Improves Surgical Outcome for Pulmonary Emphysema
Am. J. Respir. Crit. Care Med.,
December 1, 2006;
174(11):
1199 - 1205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Zeng, M.-j. Chen, D. A. Baldwin, Z.-j. Gong, J.-b. Yan, H. Qian, J. Wang, X. Jiang, Z.-r. Ren, D. Sun, et al.
Multiorgan engraftment and differentiation of human cord blood CD34+Lin- cells in goats assessed by gene expression profiling
PNAS,
May 16, 2006;
103(20):
7801 - 7806.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Nonome, X.-K. Li, T. Takahara, Y. Kitazawa, N. Funeshima, Y. Yata, F. Xue, M. Kanayama, E. Shinno, C. Kuwae, et al.
Human umbilical cord blood-derived cells differentiate into hepatocyte-like cells in the Fas-mediated liver injury model
Am J Physiol Gastrointest Liver Physiol,
December 1, 2005;
289(6):
G1091 - G1099.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Dalakas, P. N. Newsome, D. J. Harrison, and J. N. Plevris
Hematopoietic stem cell trafficking in liver injury
FASEB J,
August 1, 2005;
19(10):
1225 - 1231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Sharma, T. Cantz, R. Richter, K. Eckert, R. Henschler, L. Wilkens, A. Jochheim-Richter, L. Arseniev, and M. Ott
Human Cord Blood Stem Cells Generate Human Cytokeratin 18-Negative Hepatocyte-Like Cells in Injured Mouse Liver
Am. J. Pathol.,
August 1, 2005;
167(2):
555 - 564.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Sato, H. Araki, J. Kato, K. Nakamura, Y. Kawano, M. Kobune, T. Sato, K. Miyanishi, T. Takayama, M. Takahashi, et al.
Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion
Blood,
July 15, 2005;
106(2):
756 - 763.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Nowak, B-G Ericzon, S Nava, M Jaksch, M Westgren, and S Sumitran-Holgersson
Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo
Gut,
July 1, 2005;
54(7):
972 - 979.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Almeida-Porada, C. D. Porada, J. Chamberlain, A. Torabi, and E. D. Zanjani
Formation of human hepatocytes by human hematopoietic stem cells in sheep
Blood,
October 15, 2004;
104(8):
2582 - 2590.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Hess, T. E. Meyerrose, L. Wirthlin, T. P. Craft, P. E. Herrbrich, M. H. Creer, and J. A. Nolta
Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity
Blood,
September 15, 2004;
104(6):
1648 - 1655.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. L. Herzog, L. Chai, and D. S. Krause
Plasticity of marrow-derived stem cells
Blood,
November 15, 2003;
102(10):
3483 - 3493.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Korbling and Z. Estrov
Adult Stem Cells for Tissue Repair -- A New Therapeutic Concept?
N. Engl. J. Med.,
August 7, 2003;
349(6):
570 - 582.
[Full Text]
[PDF]
|
|
|
|
|
